Zepbound Alternative
Compounded tirzepatide, prescribed online — bilingual.
REMEVi prescribes compounded tirzepatide — a compounded preparation containing the peptide tirzepatide — through licensed US providers and state-licensed compounding pharmacies, with bilingual support and free shipping. From $269/month on the 52-week plan. Compounded tirzepatide is not FDA-approved and is not a generic version of Zepbound®.
- Licensed US providers
- FDA-registered pharmacies
- Dual GIP/GLP-1 mechanism
- Bilingual care
- Cancel anytime
The comparison
Zepbound® vs compounded tirzepatide
Compounded tirzepatide, a different regulatory pathway than Zepbound®. Not FDA-approved and not a generic of Zepbound®.
Zepbound® (Eli Lilly)
FDA-approved finished tirzepatide product for chronic weight management. SURMOUNT-1 trial showed average 22.5% body weight loss at 72 weeks at the highest dose.
- Roughly $1,000–$1,400/month without insurance
- Pen-injector format from a national-brand pharmacy
- Insurance often denies for weight-loss indication
- Has been on FDA shortage lists; fills can be inconsistent
- English-only major retail pharmacy channels
Compounded tirzepatide
Non-FDA-approved preparation made by a state-licensed US compounding pharmacy under an individual prescription. Same active pharmaceutical ingredient (tirzepatide). Not a generic of Zepbound®.
- From $269/month on 52-week plan, all-inclusive
- Licensed US providers credentialed via OpenLoop (NCQA-accredited)
- 503A / 503B compounding pharmacies under FDA registration
- Bilingual EN/ES from day one
- 5-minute intake, decision in 24 hours, ships in 5–7 days
Important: compounded tirzepatide is a non-FDA-approved preparation. It is not the same as Zepbound® and has not been clinically studied as a finished product. Trial outcomes above describe Zepbound®, not compounded preparations. Your licensed provider reviews the risks, benefits, and considerations with you before prescribing.
The process
From intake to first dose in about 7–10 days
Step 1 · 5 min
Complete the bilingual intake
Answer health-history questions in English or Spanish. Confirm BMI eligibility (BMI ≥ 27 with a weight-related condition, or BMI ≥ 30). Disclose contraindications: personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, or pancreatitis disqualifies you.
Step 2 · 24 hours
Licensed provider review
A US licensed provider — credentialed via OpenLoop's NCQA-accredited program — personally reviews your file. If clinical criteria aren't met, you're told why and not charged.
Step 3 · 5–7 days
Discreet shipping
Your compounded tirzepatide ships in cold-chain packaging from a 503A or 503B FDA-registered compounding pharmacy. Includes vial, syringes, alcohol pads, and dose-titration card.
Step 4 · Ongoing
Bilingual care, weekly titration
Dose increases on a clinical schedule (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg). Your bilingual care coordinator responds within 2 hours, EN or ES. Cancel anytime — no contracts.
Independent third-party verification
Verified by LegitScriptCertified healthcare merchant LegitScript validation ID 50384507 — recognized by Google, Meta, and major ad platforms as the legitimacy standard for online healthcare.
Common questions
Zepbound alternative FAQ
No. Zepbound® is the FDA-approved finished tirzepatide product manufactured by Eli Lilly. REMEVi prescribes compounded tirzepatide, a non-FDA-approved preparation made by a state-licensed US compounding pharmacy under an individual prescription from a licensed provider. Compounded tirzepatide contains the same active pharmaceutical ingredient (tirzepatide) but it is not a generic of Zepbound® and has not been clinically studied as a finished product. Your licensed provider reviews the risks, benefits, and considerations of compounded medication with you before prescribing.
Most patients consider a Zepbound alternative for one of three reasons: (1) Zepbound® costs roughly $1,000–$1,400 per month without insurance and many plans deny weight-loss prior authorizations; (2) Zepbound has been on FDA shortage lists, making fills inconsistent at the pharmacy counter; (3) patients in the Hispanic community often want bilingual care that brand-channel clinics can't provide. REMEVi compounded tirzepatide is prescribed by US licensed providers, prepared at state-licensed compounding pharmacies, and runs from $269/month on the 52-week plan.
Compounded tirzepatide at REMEVi is all-inclusive: monthly $379, 12-week $339/mo (Best Value), 52-week $269/mo. Every plan covers the licensed clinical evaluation, the medication itself, syringes and supplies, monthly free shipping, and a bilingual care coordinator. No lab fees, no consult fees, no surprise renewal charges.
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it works through two receptor pathways instead of one. Branded Zepbound® uses the same molecule. In the SURMOUNT-1 trial of the FDA-approved branded product, patients lost an average of 22.5% of body weight at 72 weeks at the highest dose. Those trial results describe Zepbound, not compounded preparations, which have not been clinically studied as finished products. Your licensed provider helps decide which option fits your medical history.
Yes. REMEVi is LegitScript certified (validation ID 50384507), the gold-standard third-party legitimacy program recognized by Google, Meta, and the major ad networks. Every prescription is reviewed by a US board-certified licensed provider credentialed via OpenLoop's NCQA-accredited credentialing program. Medications ship from FDA-registered 503A or 503B compounding pharmacies. The intake takes about 5 minutes and the licensed clinical review typically happens within 24 hours.
Yes — REMEVi is the only US telehealth platform built natively bilingual from day one. Intake, clinical evaluation, dosing instructions, patient portal, billing, and care coordinator communications are all available in Spanish. Care coordinators are native Spanish speakers, not translators. You can switch languages at any point in the portal without losing your history. Visit /es/alternativa-zepbound/ for the Spanish version of this page.
Resources
Learn More
Semaglutide vs. Tirzepatide: Which Is Right for You?
A side-by-side comparison of the two most popular GLP-1 weight loss medications.
Telehealth Weight Loss: How It Works
How online medical weight loss programs work and what to expect from your first visit.
GLP-1 Eligibility: Who Qualifies?
BMI thresholds, comorbidities, and contraindications for compounded GLP-1 prescriptions.
Ready to start with compounded tirzepatide?
5-minute intake. Bilingual EN/ES. Licensed provider decision in 24 hours. From $269/month.
Get started*Compounded tirzepatide is a non-FDA-approved preparation prepared by a state-licensed US compounding pharmacy under an individual prescription. It is not a generic version of, and is not the same as, Zepbound® or Mounjaro®.